Pharma

AstraZeneca Signs $555 Mn AI Deal to Identify Immunology Targets October 7, 2025 AstraZeneca has entered a $555 million collaboration with San Francisco-based Algen Biotechnologies to use artificial intelligence and CRISPR gene-editing technology for developing immunology therapies. The deal marks another major pharmaceutical move to accelerate drug discovery through AI.

Govt Invites Applications Worth INR 11,000 Cr Under PRIP to Drive Pharma-Medtech Innovation October 3, 2025 With an approved outlay of ₹5,000 crore, the scheme the PRIP scheme is expected to support around 300 projects with total R&D investment of approximately ₹11,000 crore in areas such as new medicines, complex generics, biosimilars, and advanced medical devices

Tamil Nadu to Build a 55-acre Biotech Industrial Park in Chengalpattu September 23, 2025 Tamil Nadu is moving forward with plans to develop a 55-acre Biotech Industrial Park in Chengalpattu. The park will support pharmaceuticals, vaccine production, and biotech startups, enhancing the state’s life sciences ecosystem.

Mankind Pharma to Leverage OpenAI’s GPT-5 to scale AI-enabled Pharma Transformation September 18, 2025 Mankind Pharma has partnered with OpenAI to drive AI-enabled innovation across its pharmaceutical value chain, from drug discovery to patient engagement, aiming to improve efficiency and accelerate access to healthcare solutions

SC Questions Center on Implementation of UCPMP in Pharma Sector September 9, 2025 The Supreme Court has sought clarity from the Central government on whether the Uniform Code for Pharmaceutical Marketing Practices (UCPMP), 2024 is being effectively implemented. The court raised concerns over the code’s enforcement despite its statutory framework.

Cipla Completes 20% Stake Acquisition in iCaltech Innovations August 28, 2025 Cipla has finalized the acquisition of a 20% stake in Bengaluru’s iCaltech Innovations for about ₹5 crore. The deal, first announced in July, gives Cipla voting rights and expands its respiratory devices and diagnostics portfolio.

India’s Pharma Sector Exempted from US Reciprocal Tariffs April 4, 2025 The US exempts India’s pharmaceutical industry from tariffs, reinforcing its pivotal role in global healthcare and boosting trade relations.

AI Market in Pharma to Surge Over 600% by 2034, Yet Challenges Remain: Report February 26, 2025 A new EY-Pantheon & Microsoft report predicts AI adoption in pharma will reach $16.5 billion by 2024, while AI-driven medical devices will hit $97 billion by 2028, transforming healthcare.

Zydus Restructures Leadership, Appoints New Directors February 12, 2025 Zydus Lifesciences has restructured its leadership, with Harish Sadana stepping down from Zydus Healthcare and Vijay Bhalerao appointed as Whole-Time Director.

India’s Pharma Industry Set to Reach $130 Bn by 2030: Report February 11, 2025 India’s pharmaceutical market is expected to grow to $130 billion by 2030, driven by exports, domestic demand, and innovation, according to Bain & Company.

India’s Healthcare Sector Set to Reach $320 Bn by 2028, Says Report December 27, 2024 A new report forecasts India’s healthcare sector to grow to $320 billion by 2028, driven by advancements in technology, increased investments, and expanding access to medical services.

Biocon Biologics Settles with Janssen to Launch Biosimilar Bmab 1200 Across Key Markets August 30, 2024 The agreement resolves patent disputes and sets market entry dates for Bmab 1200 in these regions, according to a stock exchange filing by Biocon.